Dermatology
Skin clinical trials
Psoriasis, eczema, skin cancers, and other conditions of the skin and connective tissue. We’re tracking 5,183 recruiting studies in this area right now.
By phase
- Not applicable2,938
- Phase 2753
- Phase 1536
- Phase 3384
- Phase 1/Phase 2296
- Phase 4212
- Phase 2/Phase 364
Top conditions
- Breast Cancer1,227
- Melanoma183
- Rheumatoid Arthritis140
- Metastatic Breast Cancer138
- Atopic Dermatitis129
- Systemic Lupus Erythematosus125
- Breast Neoplasms120
- Triple Negative Breast Cancer117
- Colorectal Cancer91
- Ovarian Cancer90
- Psoriasis88
- Breast Carcinoma82
- Lung Cancer77
- Prostate Cancer70
- Rheumatoid Arthritis (RA)66
- Diabetic Foot Ulcer61
- Systemic Sclerosis60
- Cancer58
Leading sponsors
- Fudan University66
- M.D. Anderson Cancer Center52
- Memorial Sloan Kettering Cancer Center50
- Novartis Pharmaceuticals46
- Assistance Publique - Hôpitaux de Paris41
- Mayo Clinic41
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University37
- AstraZeneca36
- National Cancer Institute (NCI)35
- Second Affiliated Hospital, School of Medicine, Zhejiang University30
Where studies are running
- California421
- Arizona159
- Florida132
- Alabama125
- New York109
- Texas107
- Massachusetts93
- Maryland91
- Pennsylvania74
- North Carolina68
Recruiting studies5,183 total
- NCT07498855Recruiting
Testing deep inspiration breath-hold for breast radiation
This trial checks how well a breathing technique (deep inspiration breath-hold) works when you have radiation to the lymph nodes in your chest. It looks at whether holding your breath during treatment helps protect your heart and lungs.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07500428Recruiting
Breast ultrasound AI study using existing images
This study uses existing breast ultrasound images to test how well artificial intelligence (AI) can interpret them. It may help improve future breast cancer detection tools.
BeijingAges 18–75 - NCT07502976Recruiting
Hair growth gel vs minoxidil for male and female hair loss
This trial tests a new gel made from a natural sugar molecule against a standard hair loss treatment (minoxidil). It aims to see which works better for people with mild to moderate hereditary hair loss.
Cairo, Cairo GovernorateAges 18–50 - NCT07503496Recruiting
Biobran supplement for breast cancer chemo support
This trial tests if a supplement called Biobran (made from rice bran) can help support people with breast cancer who are receiving chemotherapy. It may reduce side effects or improve treatment tolerance.
TaichungAges 20–65 - NCT07503652RecruitingPhase 4
Xeligekimab for moderate to severe palmoplantar pustulosis
This study tests a new drug (Xeligekimab) for people with moderate to severe palmoplantar pustulosis — a condition causing painful blisters on the hands and feet. It may be an option if other treatments haven't worked well.
ShenyangAges 18–75 - NCT07503717Recruiting
Brain scan surveillance in HER2-positive metastatic breast cancer
This study tests whether regular brain scans (surveillance) help spot brain metastases early in people with HER2-positive breast cancer that has spread to other parts of the body. Participation involves being randomly assigned to either routine brain scans or no extra scans to see which approach is better.
BeaumontAges 18 years+ - NCT07503704Recruiting
Studying breast cancer that spread to the brain
This study looks at genetic material from spinal fluid to better understand breast cancer that has spread to the brain or its lining. It may help doctors find new ways to treat this type of cancer.
DublinAges 18–99 - NCT07503808RecruitingPhase 1
IDE034 for advanced solid tumors with B7-H3 or PTK7
This study tests a new drug called IDE034 for people with advanced solid tumors that have certain markers (B7-H3 and PTK7). The drug may help by targeting these markers on cancer cells, and the study checks if it is safe and effective.
Denver, ColoradoAges 18 years+ - NCT07504367Recruiting
AI assistance in tumor treatment meetings
This study tests whether a large language model can help doctors make better decisions in tumor multidisciplinary team meetings. It evaluates junior doctors with specific experience levels.
Guangzhou, GuangdongAges 25–33 - NCT07504757Recruiting
Leishmaniasis in Children: A Study
This study watches how leishmaniasis affects children over time. It helps doctors learn more about the disease in kids so they can improve care.
Florence, TuscanyAges Up to 17 years - NCT07505797Recruiting
Ultrasound imaging study for suspicious breast lesions
This study is testing a new ultrasound device (ATUSA) to see how well it can image breast lesions that have been classified as suspicious (BI-RADS 4 or 5). If you have a recent finding that needs further evaluation, this research might help improve detection methods.
Sacramento, CaliforniaAges 18–94 - NCT07507201RecruitingEarly Phase 1
Car-T cells for autoimmune diseases like lupus
This trial tests whether specially-engineered immune cells (CAR-T cells) can help people with certain autoimmune diseases that haven't gotten better with standard treatments. The cells are designed to target and remove faulty B cells that are causing the immune system to attack the body.
Hangzhou, ZhejiangAges 3 years+ - NCT07507890Recruiting
Nipple-sparing mastectomy through one armpit incision
This trial tests a less invasive surgery for early-stage breast cancer that removes breast tissue through a single small cut in the armpit while keeping the nipple. It may be an option for women with small to medium breasts who are candidates for immediate breast reconstruction.
Candiolo, TurinAges 18 years+ - NCT07510061Recruiting
How your body handles mild heat
This study looks at how your body responds to mild heat depending on where you live and your specific traits. If you are a healthy adult in Denmark or Greece, you may be able to help researchers understand differences in heat resilience.
CopenhagenAges 18–65 - NCT07510698Recruiting
Same-day awake mastectomy with immediate breast reconstruction
This study tests whether people can have a mastectomy while awake (using numbing medicine instead of general anesthesia) and go home the same day with immediate breast reconstruction. It may be an option if you're healthy enough and have support at home.
Rome, RomeAges 18–75 - NCT07510802RecruitingPhase 1/Phase 2
CAR-NK cells for advanced HER2+ or triple-negative breast cancer
This trial tests a new type of immune cell therapy (CAR-NK cells) that targets specific proteins on breast cancer cells. It's for people with advanced HER2-positive or triple-negative breast cancer who have tried other treatments or can't take them.
Shenzhen, GuangdongAges 18–75 - NCT07513311Recruiting
Nurse Support Program for Triple-Negative Breast Cancer
This study tests a nurse-led coping and support program for people who recently finished treatment for triple-negative breast cancer. The program is designed to help you manage stress and emotional distress after treatment.
Boston, MassachusettsAges 18 years+ - NCT07515326Recruiting
Physical Activity and Wellbeing Study for Breast Cancer Patients
This study follows women with breast cancer who are enrolled in KHEOPS, a physical activity program offered at Centre Léon Bérard. Researchers will track how the program affects your motivation, mood, and quality of life through weekly online surveys.
LyonAges 18 years+ - NCT07516496Recruiting
Understanding Body Chemistry in Vascular Ehlers-Danlos Syndrome
This study looks at how bodies with vascular Ehlers-Danlos syndrome (vEDS) process nutrients and energy differently. By comparing people with vEDS to healthy volunteers, researchers hope to find new ways to manage the condition better.
CambridgeAges 18–85 - NCT07517198RecruitingPhase 1
EXS74539 Study for Advanced Solid Tumors
This is an early-stage study testing a new cancer drug called EXS74539 to find the right dose and see how well it works in people with various advanced solid tumors. The drug may help patients whose cancers have stopped responding to standard treatments.
Los Angeles, CaliforniaAges 18 years+ - NCT07517250Recruiting
Study of Canakinumab for Fever and Joint Disease
This is a study looking back at patients who were already treated with a medicine called canakinumab for familial Mediterranean fever or Still's disease (rare conditions that cause fevers and joint pain). Researchers want to understand how well this medicine worked over time and what happened to patients who took it.
BaselAges 1 year+ - NCT07517575RecruitingPhase 2
Olokizumab for Children with Juvenile Idiopathic Arthritis
This trial tests a new medicine called olokizumab in children and teenagers with juvenile idiopathic arthritis (JIA)—a condition where the immune system causes joint inflammation and pain. The study checks if this drug is safe and effective for children whose arthritis hasn't improved enough with standard treatments.
Kazan'Ages 2–17 - NCT07520760RecruitingPhase 2
Eribulin Plus Anlotinib for HER2-Negative Breast Cancer
This trial tests a combination of two cancer drugs (eribulin and anlotinib) for women whose breast cancer has spread and stopped responding to previous treatments, particularly antibody-drug conjugates. The study aims to see if this combination can help slow or shrink the cancer.
GuangzhouAges 18 years+ - NCT07523542RecruitingPhase 1/Phase 2
CAR-T Cell Therapy for Treatment-Resistant Lupus
This study tests a new type of immune cell therapy (CAR-T cells) designed to target and reduce the immune cells driving lupus in patients whose disease hasn't responded to standard treatments. Researchers will first identify which specific immune cells are causing your lupus, then engineer your own immune cells to fight them.
Shenzhen, GuangdongAges 18–70
Common questions
- How many skin clinical trials are recruiting?
- Clin2 is tracking 5,183 recruiting dermatology studies from the U.S. registry right now, out of 8,336 we cover in this area in total.
- What does “Skin” cover here?
- Psoriasis, eczema, skin cancers, and other conditions of the skin and connective tissue. We group each study into skin based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a skin trial near me?
- Use the search to filter skin studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.